Tuesday, 1 March 2016

United States Pain Management Therapeutics Market Opportunity

Pain management is one of the fastest growing medical disciplines that reduce chronic pain. Chronic pain afflicts a large population in the United States. The pain management therapeutics market in United States has huge potential for growth as high population is affected by medically significant pain. The pain management market is fuelled by the segment like arthritis pain, cancer pain, fibromyalgia, back pain, neuropathic pain, migraine pain, and post-operative pain relief markets.

Pain is a widespread problem across the United States. The pain management market is growing fuelled by cancer pain, back pain, and post-operative pain relief markets. Currently, the management of pain is not efficient due to low diagnosis and prescription rates. In most of the cases, such as cancer pain, 50% of the people taking medicines are not satisfied with the results. This is mainly due to the absence of a perfect pain management solution. Pain management can be highly effective only when the underlying disease conditions are cured.


 
The pain management therapeutics market has huge potential for growth due to the large population that is affected by medically significant pain. The new product approvals and increase in incidence and mortality of chronic conditions will continue to play a significant role in the growth and further development of this market. The higher demand for more efficient drugs for pain treatment is driving the pain-management therapeutics market. Other factors affecting the future of the pain-management segment include an increasing number of surgical procedures being performed, changing lifestyles, and increasing incidences of cancer. The United States market for pain-management therapeutics is predicted to generate over US$ 55 Billion by 2018.

The arthritis pain management therapeutic market is the leading segment of United States pain management market. Back pain is the second largest segment of the United States pain management market. Cancer pain therapeutics market is giving tough competition to back pain. The United States has an increasing incidence of cancer and cancer pain. This provides generous opportunity for market growth and product innovation. The cancer pain management market is likely to be the fastest growing segment within the pain management therapeutics market. The United States market for migraine pain is driven by products with a specific indication for migraine pain such as Imitrex and Zomig. According to Renub Research the pediatric pain management market represents the smallest segment for the pain management.

No comments:

Post a Comment